CIDE-B Inhibitors
Chemical inhibitors of CIDE-B encompass a diverse group of compounds that potentially influence its activity by targeting various aspects of metabolic regulation, including lipid metabolism, energy balance, and apoptosis. The primary mechanism of action for these inhibitors involves the modulation of metabolic pathways associated with lipid processing and energy balance. Compounds like Metformin, Rosiglitazone, Fenofibrate, Pioglitazone, and Berberine target key metabolic regulators such as AMPK and PPARs, thereby indirectly affecting CIDE-B's role in lipid metabolism. Statins, including Atorvastatin and Simvastatin, by inhibiting cholesterol synthesis, can also influence the activity of CIDE-B in lipid metabolism.
The second group of compounds includes natural modulators and specific metabolic inhibitors. Omega-3 fatty acids, Resveratrol, Acipimox, Nicotinamide, and Ezetimibe exert their effects by altering lipid profiles, activating sirtuins, influencing NAD+ metabolism, or inhibiting cholesterol absorption. These changes in metabolic processes can indirectly impact CIDE-B's function in lipid metabolism and cell apoptosis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
AMPK activator; can indirectly affect CIDE-B by modulating lipid metabolism and energy balance. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
PPARγ agonist; might impact CIDE-B by influencing lipid metabolism and insulin sensitivity. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
HMG-CoA reductase inhibitor; can indirectly affect CIDE-B by altering cholesterol synthesis and lipid metabolism. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Another HMG-CoA reductase inhibitor; can influence CIDE-B by modulating cholesterol and lipid metabolism. | ||||||
Acipimox | 51037-30-0 | sc-203497 sc-203497A | 50 mg 100 mg | $79.00 $131.00 | ||
Niacin derivative; can potentially affect CIDE-B by influencing lipid metabolism and lipolysis. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
NAD+ precursor; might impact CIDE-B by affecting pathways involved in energy metabolism and lipid processing. | ||||||
Ezetimibe | 163222-33-1 | sc-205690 sc-205690A | 25 mg 100 mg | $96.00 $241.00 | 12 | |
Cholesterol absorption inhibitor; can indirectly influence CIDE-B by altering lipid metabolism and cholesterol uptake. | ||||||